Stockscreener 앱 받기
1.68
15.86%
0.23
Tiziana Life Sciences Ltd 주식(TLSA)의 최신 뉴스
History Review: Can Tiziana Life Sciences Ltd sustain earnings growthEarnings Risk Summary & High Accuracy Trade Alerts - baoquankhu1.vn
Guidance Update: Is Tiziana Life Sciences Ltd likely to announce a buybackPortfolio Growth Summary & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Tiziana Life Sciences closes $8.8 million registered direct offering By Investing.com - Investing.com Nigeria
Orrick Advises Tiziana Life Sciences on Nasdaq Registered Direct Offering of Up to Approximately $17.6 Million - orrick.com
Tiziana Life Sciences Closes $8.8 Million Direct Offering of 7.04 Million Shares - Intellectia AI
Tiziana Life Sciences Raises $8.8 Million in Oversubscribed Direct Offering to Fund Phase 2 Trials - TipRanks
Tiziana Life Sciences announces closing of oversubscribed $8.8M offering - Proactive financial news
Tiziana Life Sciences closes $8.8 million registered direct offering - Investing.com
Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares - Benzinga
Tiziana leaders invest in $8.8M raise to finish Phase 2 na-SPMS, MSA trials - Stock Titan
Volatility Watch: What is Verastem Incs P E ratio telling usJuly 2025 Setups & Safe Entry Point Alerts - baoquankhu1.vn
Small cap wrap: Nextech3D.ai, Aftermath Silver, Tiziana Life Sciences, AtaiBeckley… - Proactive financial news
Tiziana Life Sciences unveils registered direct offering of up to $17.6M - Proactive financial news
Tiziana Life Sciences Raises Up to $17.6 Million in Insider-Led Direct Offering to Fund Phase 2 Trials - TipRanks
Tiziana Life Sciences Announces $8 Million Registered Direct Offering of Ordinary Shares to Support Clinical Trials - Quiver Quantitative
CEO backs $17.6M Tiziana raise to fund key na-SPMS and MSA trials - Stock Titan
Layoff Watch: How Tiziana Life Sciences Ltd stock reacts to oil pricesJuly 2025 Movers & Safe Entry Momentum Stock Tips - Bộ Nội Vụ
Aug Ideas: Is Tiziana Life Sciences Ltd stock gaining market share2025 Top Gainers & Weekly Breakout Watchlists - Bộ Nội Vụ
Tiziana Life Sciences to Showcase Intranasal Foralumab at Neuroscience Innovation Forum During JPM Week - TipRanks
US Stocks Recap: Can Columbia Sportswear Company stock sustain revenue growthJuly 2025 Technicals & Target Return Focused Stock Picks - moha.gov.vn
Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco - 富途牛牛
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - MSN
Tiziana Life Sciences Shares Drop After Company Unveils Plan to Spin Out IL-6 Program - MSN
Tiziana Life Sciences to present at 9th Annual Neurosciences Innovation Forum - Proactive financial news
Townhall - FinancialContent
Why Tiziana Life Sciences Ltd stock is rated strong buyQuarterly Portfolio Review & Safe Swing Trade Setup Alerts - Улправда
Tiziana Life Sciences Ltd Share Price (TLSA.US) - London South East
Tiziana Life Sciences (NASDAQ:TLSA) Trading Up 7.4% – Still a Buy? - Defense World
Tiziana Life Sciences (NASDAQ:TLSA) Trading Up 7.4%Still a Buy? - MarketBeat
Tiziana Life Sciences Files Annual Safety Report for Intranasal Foralumab with FDA - marketscreener.com
Tiziana Life Sciences files annual safety report for intranasal foralumab - Yahoo Finance
Is Tiziana Life Sciences Ltd a good long term investmentSupport and Resistance Levels & Free Risk Assessment and Control - earlytimes.in
Tiziana Life Sciences submits annual safety report for intranasal foralumab to FDA - Proactive financial news
Tiziana Life Sciences Reports Positive Safety Profile for Intranasal Foralumab Following 37.4 Patient-Years of Exposure - Quiver Quantitative
Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA - The Manila Times
Small cap wrap: Tiziana Life Sciences, 374Water, First Phosphate... - Proactive financial news
Operating expenses (excl. COGS) of Tiziana Life Sciences Ltd. – GETTEX:0RP - TradingView — Track All Markets
Tiziana Life Sciences begins dosing in Phase 2 Alzheimer’s trialICYMI - Proactive financial news
Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman - The Manila Times
Tiziana Life Sciences Chair Boosts Stake to 36% with December Share Purchase - TipRanks
How buybacks impact Tiziana Life Sciences Ltd stock valueRecession Risk & Reliable Breakout Stock Forecasts - Улправда
Tiziana Life Sciences chairman increases stake to over 36% By Investing.com - Investing.com South Africa
Tiziana Life Sciences (TLSA) Chairman Expands Stake in the Compa - GuruFocus
Tiziana Life Sciences executive chairman increases stake - Proactive financial news
Why Tiziana Life Sciences Ltd stock is considered a top pickWeekly Stock Summary & Daily Risk Controlled Trade Plans - Bölüm Sonu Canavarı
Tiziana Life Sciences Executive Chairman Gabriele Cerrone Acquires Additional Shares, Increasing Ownership to 36.08% - Quiver Quantitative
Tiziana Life Sciences chairman increases stake to over 36% - Investing.com
Biotech founder lifts personal stake to 36% with latest share buy - Stock Titan
Can Tiziana Life Sciences Ltd stock maintain operating marginsShort Setup & Free Weekly Chart Analysis and Trade Guides - Улправда
Is Tiziana Life Sciences Ltd stock a buy on dipsIPO Watch & Safe Entry Zone Tips - DonanımHaber
Is Tiziana Life Sciences Ltd stock gaining market share2025 Market Overview & Daily Volume Surge Signals - Улправда
What risks investors should watch in Tiziana Life Sciences Ltd stockJuly 2025 Setups & Free Low Drawdown Momentum Trade Ideas - Улправда
How Tiziana Life Sciences Ltd stock performs during Fed tightening cyclesJuly 2025 Intraday Action & Stepwise Swing Trade Plans - Улправда
Tiziana Life Sciences doses first patient in mid-stage Alzheimer’s trial - Proactive financial news
Tiziana Life Sciences Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Small cap wrap: Tiziana Life Sciences, NanoViricides, 1911 Gold, Protalix BioTherapeutics… - Proactive Investors
4.73%
0.92%
자본화:
|
볼륨(24시간):